{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T14:01:53Z","timestamp":1782828113223,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,6]]},"DOI":"10.7759\/cureus.78626","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T14:33:27Z","timestamp":1738852407000},"source":"Crossref","is-referenced-by-count":1,"title":["Hepatotoxicity From Disease-Modifying Anti-rheumatic Drugs (DMARDs) and Association With Metabolic Syndrome in Rheumatoid Arthritis"],"prefix":"10.7759","author":[{"given":"Abhishek","family":"Nandan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josna","family":"Haritha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Maniscalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huzaefah","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12184","article-title":"A review of methotrexate-associated hepatotoxicity","volume":"15","author":"Bath RK","year":"2014","unstructured":"Bath RK, Brar NK, Forouhar FA, Wu GY. A review of methotrexate-associated hepatotoxicity. J Dig Dis. 2014, 15:517-24. 10.1111\/1751-2980.12184","journal-title":"J Dig Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320202","article-title":"Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples","volume":"32","author":"Kremer JM","year":"1989","unstructured":"Kremer JM, Lee RG, Tolman KG. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples. Arthritis Rheum. 1989, 32:121-7. 10.1002\/anr.1780320202","journal-title":"Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12847","article-title":"Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis","volume":"29","author":"Candia R","year":"2015","unstructured":"Candia R, Ruiz A, Torres-Robles R, Ch\u00e1vez-Tapia N, M\u00e9ndez-S\u00e1nchez N, Arrese M. Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2015, 29:656-62. 10.1111\/jdv.12847","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.21.2542","article-title":"Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group","volume":"159","author":"Strand V","year":"1999","unstructured":"Strand V, Cohen S, Schiff M, et al.. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med. 1999, 159:2542-50. 10.1001\/archinte.159.21.2542","journal-title":"Arch Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-2-199701150-00008","article-title":"Nonalcoholic steatohepatitis","volume":"126","author":"Sheth SG","year":"1997","unstructured":"Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med. 1997, 126:137-45. 10.7326\/0003-4819-126-2-199701150-00008","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-10-200511150-00009","article-title":"The metabolic syndrome as a predictor of nonalcoholic fatty liver disease","volume":"143","author":"Hamaguchi M","year":"2005","unstructured":"Hamaguchi M, Kojima T, Takeda N, et al.. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005, 143:722-8. 10.7326\/0003-4819-143-10-200511150-00009","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13442","article-title":"Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate","volume":"22","author":"Lertnawapan R","year":"2019","unstructured":"Lertnawapan R, Chonprasertsuk S, Siramolpiwat S. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate. Int J Rheum Dis. 2019, 22:214-21. 10.1111\/1756-185X.13442","journal-title":"Int J Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2001.02644.x","article-title":"Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury","volume":"16","author":"Langman G","year":"2001","unstructured":"Langman G, Hall PM, Todd G. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury. J Gastroenterol Hepatol. 2001, 16:1395-401. 10.1046\/j.1440-1746.2001.02644.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.12.034","article-title":"Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated","volume":"78","author":"Atallah E","year":"2023","unstructured":"Atallah E, Grove JI, Crooks C, et al.. Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated. J Hepatol. 2023, 78:989-97. 10.1016\/j.jhep.2022.12.034","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin L","year":"2003","unstructured":"Sandrin L, Fourquet B, Hasquenoph JM, et al.. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003, 29:1705-13. 10.1016\/j.ultrasmedbio.2003.07.001","journal-title":"Ultrasound Med Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1646-4","article-title":"Causes of DMARD withdrawal following ADR within 6 months of initiation among Indian rheumatoid arthritis patients","volume":"32","author":"Mittal N","year":"2012","unstructured":"Mittal N, Sharma A, Jose V, Mittal R, Wanchu A, Bambery P. Causes of DMARD withdrawal following ADR within 6 months of initiation among Indian rheumatoid arthritis patients. Rheumatol Int. 2012, 32:743-8. 10.1007\/s00296-010-1646-4","journal-title":"Rheumatol Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-30102","article-title":"Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs","volume":"22","author":"Chitturi S","year":"2002","unstructured":"Chitturi S, George J. Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs. Semin Liver Dis. 2002, 22:169-83. 10.1055\/s-2002-30102","journal-title":"Semin Liver Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.214","article-title":"Hepatotoxicity related to antirheumatic drugs","volume":"7","author":"Aithal GP","year":"2011","unstructured":"Aithal GP. Hepatotoxicity related to antirheumatic drugs. Nat Rev Rheumatol. 2011, 7:139-50. 10.1038\/nrrheum.2010.214","journal-title":"Nat Rev Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-015-0366-9","article-title":"Hepatotoxicity associated with the use of anti-TNF-\u03b1 agents","volume":"39","author":"French JB","year":"2016","unstructured":"French JB, Bonacini M, Ghabril M, Foureau D, Bonkovsky HL. Hepatotoxicity associated with the use of anti-TNF-\u03b1 agents. Drug Saf. 2016, 39:199-208. 10.1007\/s40264-015-0366-9","journal-title":"Drug Saf"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep176","article-title":"Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate","volume":"48","author":"Amital H","year":"2009","unstructured":"Amital H, Arnson Y, Chodick G, Shalev V. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate. Rheumatology (Oxford). 2009, 48:1107-10. 10.1093\/rheumatology\/kep176","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/306040-hepatotoxicity-from-disease-modifying-anti-rheumatic-drugs-dmards-and-association-with-metabolic-syndrome-in-rheumatoid-arthritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T14:33:28Z","timestamp":1738852408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/306040-hepatotoxicity-from-disease-modifying-anti-rheumatic-drugs-dmards-and-association-with-metabolic-syndrome-in-rheumatoid-arthritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.78626","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,6]]}}}